Thrombocytopenia and cancer.
Eklund
Elizabeth A
EA
Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine of Northwestern University, Olsen 8524, 710 N Fairbanks Court, Chicago, IL 60611, USA. e-eklund@northwestern.edu
D051722:ADAM Proteins / Q000502:physiology; D000071120:ADAMTS13 Protein; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001855:Bone Marrow Diseases / Q000139:chemically induced; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000209:etiology; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000150:complications*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000097:blood / Q000139:chemically induced / Q000209:etiology; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood / Q000209:etiology; D013921:Thrombocytopenia / Q000097:blood / Q000175:diagnosis / Q000209:etiology*
D000970:Antineoplastic Agents; D006493:Heparin; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human